NL-OMON28691招募中不适用
The effects of structured follow-up from primary care for patients during their cancer journey. A randomized controlled trial.
niversitair Medisch Centrum Utrecht (UMCU)0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Newly diagnosed with the following types of cancer: breast cancer, colorectal cancer, gynaecologic cancer, lung cancer or melanoma.
- •2) Cancer therapy is to be initiated with curative intent.
排除标准
- •1) Major psychiatric disease and personality disorders.
- •2) Unable to fill in questionnaires.
研究者
相似试验
招募中
不适用
Influence of structured follow up in First seizure clinic on anxiety of parents and children after first, unprovoked seizure- a randomized, controlled pilot studyEpileptic seizureR56.8Other and unspecified convulsionsDRKS00011736Klinik für Neuropädiatrie und Muskelerkrankungen, Zentrum für Kinder- und Jugendheilkunde des Universitätsklinikums Freiburg40
已完成
不适用
A prospective study of appropriate follow-up interval for high-risk group of branch duct type intraductal papillary mucinous neoplasms of the pancreasJPRN-UMIN000016989Sendai City Medical Center155
Enrolling By Invitation
不适用
Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer SurgeryPancreas CancerDiabetesNCT06774170Dokuz Eylul University40
进行中（未招募）
1 期
ong-Term Follow-Up of Subjects in a Phase 1, 2, or 3 CLinical Trial in Which Boceprevir or Narlaprevir was Administered for the Treatment of Chronic Hepatitis Cong-term Follow-up of prior study participantsMedDRA version: 14.0Level: PTClassification code 10019641Term: Hepatic cirrhosisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2006-006529-25-DESchering-Plough Research Institute1,954
进行中（未招募）
不适用
ong-Term Follow-Up of Subjects in a Phase 1, 2, or 3 CLinical Trial in Which Boceprevir or Narlaprevir was Administered for the Treatment of Chronic Hepatitis CEUCTR2006-006529-25-PTMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.2,800